MARKET

ELTX

ELTX

Elicio Therapeutics, Inc.
NASDAQ
10.08
-0.36
-3.45%
After Hours: 10.08 0 0.00% 16:10 03/30 EDT
OPEN
10.50
PREV CLOSE
10.44
HIGH
11.00
LOW
9.91
VOLUME
175.73K
TURNOVER
--
52 WEEK HIGH
14.93
52 WEEK LOW
4.600
MARKET CAP
185.43M
P/E (TTM)
-3.9006
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELTX last week (0323-0327)?
Weekly Report · 20h ago
Weekly Report: what happened at ELTX last week (0316-0320)?
Weekly Report · 03/23 09:57
Elicio Therapeutics reports inducement grants
TipRanks · 03/17 12:15
Elicio Therapeutics reports 1,600 inducement stock options priced at USD 12.16 per share
Reuters · 03/17 12:02
Elicio Therapeutics Launches New $100 Million ATM Program
TipRanks · 03/16 14:05
Elicio Therapeutics Launches $100M At-The-Market Offering Program, Replaces Prior $40M Sales Agreement
Benzinga · 03/16 13:29
Elicio Therapeutics signs ATM equity distribution agreement for up to USD 100 million
Reuters · 03/16 13:20
ELICIO THERAPEUTICS INC FILES FOR OFFERING OF UP TO $100 MLN COMMON STOCK - SEC FILING
Reuters · 03/16 13:20
More
About ELTX
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of immunotherapies for the treatment of cancer. The Company provides a platform, amphiphile (AMP) that delivers immunotherapeutics directly to the lymph nodes (brain center) of the immune system. The Company’s clinical and preclinical pipeline includes the lymph node targeted therapeutic cancer vaccines ELI-002, which is being evaluated in a Phase II study, designed to stimulate an immune response against mutant kirsten rat sarcoma (KRAS). Its ELI-007 is being evaluated in a preclinical study for the treatment of mutant v-raf murine sarcoma viral oncogene homolog B1 (BRAF) driven cancers, and ELI-008, is being evaluated in a preclinical study for use in the treatment of mutated tumor protein p53 (TP53) expressing cancers.

Webull offers Angion Biomedica Corp stock information, including NASDAQ: ELTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELTX stock methods without spending real money on the virtual paper trading platform.